Conmed (CNMD) reported earnings 30 days ago. What's next for the stock?
CNMD's 16% monthly rally is backed by stronger growth, margin gains and raised earnings guidance, but cash-flow and execution risks remain.
CONMED raised its 2026 adjusted EPS outlook after a strong second quarter, but slower organic growth and higher financing costs keep the setup mixed.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
Curtis Ellergodt Rothschild Investment LLC | 30 | $1,562.53 | $1,479 | -$83.53 | -5.35% |
| PER Paul E. Rasmussen SIT INVESTMENT ASSOCIATES Inc. | 3,060 | $100,000 | $151,714.8 | $51,714.8 | 51.71% |
| NA Nizar Araji National Bank Of Canada /FI/ | 237 | $13,011.61 | $11,641.44 | -$1,370.17 | -10.53% |
| SN Stephanie Nee HARBOR CAPITAL ADVISORS Inc. | 26,628 | $1.36M | $1.31M | -$53,844.15 | -3.95% |
| BG Bart Gancher Intech Investment Management LLC | 6,213 | $252,247.8 | $307,294.98 | $55,047.18 | 21.82% |
| Health Care Equipment & Supplies Industry | Healthcare Sector | Patrick J. Beyer CEO | NYSE Exchange | 207410101 CUSIP |
| US Country | 3,900 Employees | 15 Sep 2025 Last Dividend | 10 Sep 2001 Last Split | 23 Jul 1987 IPO Date |
CONMED Corporation is an influential player in the medical technology sphere, with a focus on the development, manufacturing, and global sales of surgical devices and related equipment. This company caters to a broad spectrum of surgical procedures, providing innovative solutions that aim to enhance clinical outcomes for patients around the world. Operating under various esteemed brands, including Hall, CONMED Linvatec, Concept, and Shutt, the corporation has established a strong reputation for quality and innovation since its inception in 1970. Headquartered in Largo, Florida, CONMED Corporation takes a direct approach to marketing its products, targeting hospitals, surgery centers, and other healthcare institutions while also leveraging medical specialty distributors for broader reach.